EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?

U Protzer, H Abken

Hepatitis Research and Treatment · 2010

DOI: 10.1155/2010/901216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von U Protzer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Virologie, Technische Universität München/Helmholtz Zentrum München, 81675 München, Germany. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Deutsche Forschungsgemeinschaft, European Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary. While a vaccine is available and new antiviral drugs are being developed, elimination of persistently infected cells is still a major issue. Recent efforts in adoptive cell therapy are experimentally exploring immunotherapeutic elimination of HBV-infected cells by means of a biological attack with genetically engineered “designer” T cells.

Autor:innen und Institutionen

  • Institut für Virologie, Technische Universität München/Helmholtz Zentrum München, 81675 München, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • European Commission

Zitieren

APA

Protzer, U., & Abken, H. (2010). Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/901216

Vancouver

Protzer U, Abken H. Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/901216

BibTeX
@article{Protzer2010,
  author = {Protzer, U and Abken, H},
  title = {Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?},
  journal = {Hepatitis Research and Treatment},
  year = {2010},
  doi = {10.1155/2010/901216}
}
Kostenlos starten →